Tag Archives: FDA
Why We Oppose Dr. Janet Woodcock to Head the FDA
President Biden will soon nominate a Commissioner U.S. Food & Drug Administration. Dr. Janet Woodcock is the current acting FDA commissioner and is a potential candidate for the position. We oppose Woodcock’s potential nomination and sent the letter below to The Honorable... Read more
Posted in Articles
FDA Commissioner: take action to protect strong leadership
By Krystal Redman, DrPH, Executive Director
We have an urgent action request for you: contact your legislators today and let them know you strongly oppose Dr. Janet Woodcock for Food and Drug Administration (FDA) Commissioner.
The FDA has granted more new drug... Read more
Posted in BCA Action Alerts, E-Alerts
Take action: demand strong FDA leadership
By Jayla Burton, Program Manager
Since day one of President Joe Biden taking office, we’ve called on him to make sure his administration makes breast cancer a priority. Appointing a strong Food and Drug Administration (FDA) leader who will focus on protecting the health and... Read more
Posted in BCA Action Alerts, E-Alerts
Tell the Biden-Harris administration we need action
By Jayla Burton, Program Officer
A new administration doesn’t mean our work is done—it means we work even harder to address and end breast cancer.
Over the last few years, it seems like we have seen it all. We've experienced the deprioritization of science,... Read more
Posted in BCA Action Alerts, E-Alerts
Looking back and moving forward
By Marj Plumb, DrPH, Interim Executive Director July 2020 to January 2021, and Karuna Jaggar, Former Executive Director, March 2011 to June 2020
2020 was a year that reminded us all why Breast Cancer Action’s uncompromising health justice work is so important—even while... Read more
Posted in E-Alerts
SABCS 2020
By Jayla Burton, Program Officer
For decades billions of dollars have been poured into breast cancer research. And each December clinicians and researchers from around the world gather at the San Antonio Breast Cancer Symposium (SABCS) to share the latest study results. For... Read more
SABCS 2020: Patient-centered FDA Approvals
By Tibby Reas Hinderlie, Communications Officer
I joined Breast Cancer Action as the Communications Officer in July of 2020, which makes this year’s San Antonio Breast Cancer Symposium (SABCS) my first breast cancer conference. Given that SABCS is geared towards clinicians... Read more
Posted in Articles
Think Before You Pink® ends this weekend
By Marj Plumb, DrPH, Interim Executive Director
Thank you for everything you’ve done this month to tell the administration and our federal agencies that We Can’t Be Pink’d!
Together we held four federal agencies accountable. If you missed any of these actions,... Read more
Posted in BCA Action Alerts, E-Alerts
We Can’t Be Pink’d Personal Video Stories
THINK BEFORE YOU PINK® – 2020 CAMPAIGN
We've been lucky enough to have three Breast Cancer Action members share their stories of why our We Can't Be Pink'd actions are important to them.
Kim Motta and Deb Smalley shared their stories of breast implant illness... Read more
Posted in BCA Action Alerts
Last week to say We Can’t Be Pink’d!
By Marj Plumb, Interim Executive Director
This has been a Think Before You Pink® campaign unlike any other. We’ve never run a campaign this big before, with four distinct targets. And there's still time to participate - all four actions are linked below!
On... Read more
Posted in BCA Action Alerts, E-Alerts
a project of Breast Cancer Action